Tesamorelin acts on pituitary somatotroph cells to stimulate growth hormone (GH) secretion in a pulsatile, physiologically mimetic pattern
You get a one-page summary of MHRA status, CE mark status, FDA status, and the GPhCs stated concerns, so the decision is informed
ChambersESByrneCSMorrisonDJMurphyKGPrestonTTedfordCet al
Sermorelin, on the other hand, closely mimics the bodys natural growth hormone-releasing hormone (GHRH), which may result in a more natural and pulsatile release of growth hormone
When you stop taking the medication, these effects dissipate within days to weeks as the drug clears from your system (tirzepatide has a half-life of approximately 5 days according to the FDA prescribing information)
These drugs are often paired with other treatments, and knowing how they work together is key to ensuring cardiovascular safety